Loading
Latest filing published 21 Apr 2011 for Emmaus Life Sciences, Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by Timothy Brasel span 3 companies, the busiest being Birch Branch Inc, American Clean Resources Group, Inc. and Emmaus Life Sciences, Inc. We count 15 filings; the first trade dates from 23 January 2007 and the latest from 16 February 2011.
The open-market side counts 2 purchases for €926.0M alongside 8 sales for €30k. The net balance comes to €926.0M on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2011 to date brings 1 purchase and no sales.
The record was last updated on 21 April 2011 with an open-market purchase (€926.0M) in Emmaus Life Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 8 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations